2 studies found for:    2523562 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated interferon alpha-2b;   Drug: Ribavirin;   Drug: pegylated Interferon alpha-2b
2 Enrolling by invitation Identification of Viruses Associated With Diseases of Unknown Cause
Condition: Viral Diseases

Indicates status has not been verified in more than two years